Registro:

Referencias:

• Abdul, M., Logothetis, C.J., Hoosein, N.M., Growth-inhibitory effects of serotonin uptake inhibitors on human prostate carcinoma cell lines (1995) J. Urol., 154, pp. 247-250
• Alvaro, T., Lejeune, M., García, J.F., Salvadó, M.T., López, C., Bosch, R., Jaén, J., Pons, L.E., Tumor-infiltrated immune response correlates with alterations in the apoptotic and cell cycle pathways in Hodgkin and Reed-Sternberg cells (2008) Clin. Cancer Res., 14, pp. 685-691
• Arimochi, H., Morita, K., Characterization of cytotoxic actions of tricyclic antidepressants on human HT29 colon carcinoma cells (2006) Eur. J. Pharmacol., 541, pp. 17-23
• Baur, A.S., Shaw, P., Burri, N., Delacretaz, F., Bosman, F.T., Chaubert, P., Frequent methylation silencing of p15(INK4b) (MTS2) and p16(INK4a) (MTS1) in B-cell and T-cell lymphomas (1999) Blood, 94 (5), pp. 1773-1781
• Brandes, L.J., Arron, R.J., Bogdanovic, R.P., Tong, J., Zaborniak, C.L., Hogg, G.R., Warrington, R.C., LaBella, F.S., Stimulation of malignant growth in rodents by antidepressant drugs at clinically relevant doses (1992) Cancer Res., 52, pp. 3796-3800
• Cheng, N., Van De Wetering, C.I., Knudson, C.M., P27 deficiency cooperates with Bcl-2 but not Bax to promote T-cell lymphoma (2008) PLoS One, 3, pp. e1911
• Coogan, P.F., Palmer, J.R., Strom, B.L., Rosenberg, L., Use of selective serotonin reuptake inhibitors and the risk of breast cancer (2005) Am. J. Epidemiol., 162, pp. 835-838
• Coogan, P.F., Strom, B.L., Rosenberg, L., Antidepressant use and colorectal cancer risk (2009) Pharmacoepidemiol. Drug Saf., 18, pp. 1111-1114
• Dredge, K., Marriott, J.B., Todryk, S.M., Dalgleish, A.G., Adjuvants and the promotion of Th1-type cytokines in tumour immunotherapy (2002) Cancer Immunol. Immunother., 51, pp. 521-531
• Dulawa, S.C., Holick, K.A., Gundersen, B., Hen, R., Effects of chronic fluoxetine in animal models of anxiety and depression (2004) Neuropsychopharmacology, 29 (7), pp. 1321-1330. , DOI 10.1038/sj.npp.1300433
• Edgar, V.A., Genaro, A.M., Cremaschi, G., Sterin-Borda, L., Fluoxetine action on murine T-lymphocyte proliferation: Participation of PKC activation and calcium mobilisation (1998) Cell. Signal., 10, pp. 721-726
• Edgar, V.A., Sterin-Borda, L., Cremaschi, G.A., Genaro, A.M., Role of protein kinase C and cAMP in fluoxetine effects on human T-cell proliferation (1999) Eur. J. Pharmacol., 372, pp. 65-73
• Eisen, J.N., Irwin, J., Quay, J., Livnat, S., The effect of antidepressants on immune function in mice (1989) Biological Psychiatry, 26 (8), pp. 805-817. , DOI 10.1016/0006-3223(89)90121-2
• El-Deiry, W.S., Harper, J.W., O'Connor, P.M., Velculescu, V.E., Canman, C.E., Jackman, J., Pietenpol, J.A., Vogelstein, B., WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis (1994) Cancer Res., 54, pp. 1169-1174
• Fazzino, F., Urbina, M., Cedeño, N., Lima, L., Fluoxetine treatment to rats modifies serotonin transporter and cAMP in lymphocytes, CD4+ and CD8+ subpopulations and interleukins 2 and 4 (2009) Int. Immunopharmacol., 9, pp. 463-467
• Foss, F.M., Immunologic mechanisms of antitumor activity (2002) Semin. Oncol., 29, pp. 5-11
• Frank, M.G., Hendricks, S.E., Johnson, D.R., Wieseler, J.L., Burke, W.J., Antidepressants augment natural killer cell activity: In vivo and in vitro (1999) Neuropsychobiology, 39 (1), pp. 18-24. , DOI 10.1159/000026555
• Frick, L.R., Palumbo, M.L., Zappia, M.P., Brocco, M.A., Cremaschi, G.A., Genaro, A.M., Inhibitory effect of fluoxetine on lymphoma growth through the modulation of antitumor T-cell response by serotonin-dependent and independent mechanisms (2008) Biochem. Pharmacol., 75, pp. 1817-1826
• Frick, L.R., Rapanelli, M., Cremaschi, G.A., Genaro, A.M., Fluoxetine directly counteracts the adverse effects of chronic stress on T cell immunity by compensatory and specific mechanisms (2009) Brain Behav. Immun., 23, pp. 36-40
• Gallardo, F., Esteller, M., Pujol, R.M., Costa, C., Estrach, T., Servitje, O., Methylation status of the p15, p16 and MGMT promoter genes in primary cutaneous T-cell lymphomas [8] (2004) Haematologica, 89 (11), pp. 1401-1403
• Garcia, J.F., Camacho, F.I., Morente, M., Fraga, M., Montalban, C., Alvaro, T., Bellas, C., Piris, M.A., Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: Analyses using tissue microarrays (2003) Blood, 101 (2), pp. 681-689. , DOI 10.1182/blood-2002-04-1128
• Geisen, C., Karsunky, H., Yucel, R., Moroy, T., Loss of p27Kip1 cooperates with cyclin e in T-cell lymphomagenesis (2003) Oncogene, 22 (11), pp. 1724-1729. , DOI 10.1038/sj.onc.1206340
• Genaro, A.M., Edgar, V.A., Sterin-Borda, L., Differential effects of fluoxetine on murine B-cell proliferation depending on the biochemical pathways triggered by distinct mitogens (2000) Biochem. Pharmacol., 60, pp. 1279-1283
• Gombart, A.F., Morosetti, R., Miller, C.W., Said, J.W., Koeffler, H.P., Deletions of the cyclin-dependent kinase inhibitor genes p16INK4A and p15INK4B in non-Hodgkin's lymphomas (1995) Blood, 86, pp. 1534-1539
• Gordon, J., Barnes, N.M., Lymphocytes transport serotonin and dopamine: Agony or ecstasy? (2003) Trends Immunol., 24, pp. 438-443
• Hosokawa, Y., Yang, M., Kaneko, S., Tanaka, M., Nakashima, K., Synergistic gene expressions of cyclin E, cdk2, cdk5 and E2F-1 during the prolactin-induced G1/S transition in rat Nb2 pre-T lymphoma cells (1995) Biochem. Mol. Biol. Int., 37, pp. 393-399
• Jia, L., Shang, Y.Y., Li, Y.Y., Effect of antidepressants on body weight, ethology and tumor growth of human pancreatic carcinoma xenografts in nude mice (2008) World J. Gastroenterol., 14, pp. 4377-4382
• Kanavaros, P., Bai, M., Stefanaki, K., Poussias, G., Rontogianni, D., Zioga, E., Gorgoulis, V., Agnantis, N.J., Immunohistochemical expression of the p53,mdm2, p21/Waf-1, Rb, p16, Ki67, cyclin D1, cyclin A and cyclin B1 proteins and apoptotic index in T-cell lymphomas (2001) Histol. Histopathol., 16, pp. 377-386
• Kang-Decker, N., Tong, C., Boussouar, F., Baker, D.J., Xu, W., Leontovich, A.A., Taylor, W.R., Van Deursen, J.M.A., Loss of CBP causes T cell lymphomagenesis in synergy with p27 Kip1 insufficiency (2004) Cancer Cell, 5 (2), pp. 177-189. , DOI 10.1016/S1535-6108(04)00022-4, PII S1535610804000224
• Karsunky, H., Geisen, C., Schmidt, T., Haas, K., Zevnik, B., Eva, G., Moroy, T., Oncogenic potential of cyclin e in T-cell lymphomagenesis in transgenic mice: Evidence for cooperation between cyclin e and Ras but not Myc (1999) Oncogene, 18 (54), pp. 7816-7824
• Kinjo, T., Kowalczyk, P., Kowalczyk, M., Walaszek, Z., Nishimaki, T., Slaga, T.J., Hanausek, M., Desipramine inhibits the growth of a mouse skin squamous cell carcinoma cell line and affects glucocorticoid receptor-mediated transcription (2009) Mol. Carcinog., 48, pp. 1123-1130
• Knutson, K.L., Disis, M.L., Tumor antigen-specific T helper cells in cancer immunity and immunotherapy (2005) Cancer Immunol. Immunother., 54, pp. 721-728
• Krawczyk, C.M., Verstovsek, S., Ujházy, P., Maccubbin, D., Ehrke, M.J., Protective specific immunity induced by cyclophosphamide plus tumor necrosis factor alpha combination treatment of EL4-lymphoma-bearing C57BL/6 mice (1995) Cancer Immunol. Immunother., 40, pp. 347-357
• Kubera, M., Basta-Kaim, A., Skowron-Cendrzak, A., Mazur-Kolecka, B., Roman, A., Borycz, J., Effect of repeated amitriptyline administration to mice on the T lymphocyte proliferative activity and natural killer cell cytotoxicity (1995) Pol. J. Pharmacol., 47, pp. 321-326
• Kubera, M., Simbirtsev, A., Mathison, R., Maes, M., Effects of repeated fluoxetine and citalopram administration on cytokine release in C57BL/6 mice (2000) Psychiatry Res., 96, pp. 255-266
• Kubera, M., Lin, A.H., Kenis, G., Bosmans, E., Van Bockstaele, D., Maes, M., Anti-inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio (2001) J. Clin. Psychopharmacol., 21, pp. 199-206
• Kubera, M., Grygier, B., Arteta, B., Urbańska, K., Basta-Kaim, A., Budziszewska, B., Leśkiewicz, M., Lasoń, W., Age-dependent stimulatory effect of desipramine and fluoxetine pretreatment on metastasis formation by B16F10melanoma inmale C57BL/6 mice (2009) Pharmacol. Rep., 61, pp. 1113-1126
• Kubera, M., Maes, M., Budziszewska, B., Basta-Kaim, A., Leśkiewicz, M., Grygier, B., Rogóz, Z., Lasoń, W., Inhibitory effects of amantadine on the production of pro-inflammatory cytokines by stimulated in vitro human blood (2009) Pharmacol. Rep., 61, pp. 1105-1112
• Kvarnstrom, M., Jenmalm, M.C., Ekerfelt, C., Effect of cryopreservation on expression of Th1 and Th2 cytokines in blood mononuclear cells from patients with different cytokine profiles, analysed with three common assays: An overall decrease of interleukin-4 (2004) Cryobiology, 49 (2), pp. 157-168. , DOI 10.1016/j.cryobiol.2004.06.003, PII S0011224004001038
• Lawlor, D.A., Jüni, P., Ebrahim, S., Egger, M.J., Systematic review of the epidemiologic and trial evidence of an association between antidepressant medication and breast cancer (2003) Clin. Epidemiol., 56, pp. 155-163
• Levkovitz, Y., Gil-Ad, I., Zeldich, E., Dayag, M., Weizman, A., Differential induction of apoptosis by antidepressants in glioma and neuroblastoma cell lines: Evidence for p-c-Jun, cytochrome c, and caspase-3 involvement (2005) J. Mol. Neurosci., 27, pp. 29-42
• Maes, M., Theimmunoregulatory effects of antidepressants (2001) Hum. Psychopharmacol., 16, pp. 95-103
• Maes, M., Kenis, G., Kubera, M., De Baets, M., Steinbusch, H., Bosmans, E., The negative immunoregulatory effects of fluoxetine in relation to the cAMP-dependent PKA pathway (2005) Int. Immunopharmacol., 5, pp. 609-618
• Martins, C.P., Berns, A., Loss of p27Kip1but not p21Cip1 decreases survival and synergizes with MYC in murine lymphomagenesis (2002) EMBO Journal, 21 (14), pp. 3739-3748. , DOI 10.1093/emboj/cdf364
• Mena, A., Ioannou, X.P., Van Kessel, A., Van Drunen, L.-V.D.H.S., Popowych, Y., Babiuk, L.A., Godson, D.L., Th1/Th2 biasing effects of vaccination in cattle as determined by real-time PCR (2002) Journal of Immunological Methods, 263 (1-2), pp. 11-21. , DOI 10.1016/S0022-1759(02)00029-7, PII S0022175902000297
• Møller, M.B., Nielsen, O., Pedersen, N.T., Cyclin D3 expression in non-Hodgkin lymphoma. Correlation with other cell cycle regulators and clinical features (2001) Am. J. Clin. Pathol., 115, pp. 404-412
• Moller, M.B., Nielsen, O., Pedersen, N.T., Frequent alteration of MDM2 and p53 in the molecular progression of recurring non-Hodgkin's lymphoma (2002) Histopathology, 41 (4), pp. 322-330. , DOI 10.1046/j.1365-2559.2002.01506.x
• Morente, M.M., Piris, M.A., Abraira, V., Acevedo, A., Aguilera, B., Bellas, C., Fraga, M., Montalban, C., Adverse clinical outcome in Hodgkin's disease is associated with loss of retinoblastoma protein expression, high Ki67 proliferation index, and absence of Epstein-Barr Virus-latent membrane protein 1 expression (1997) Blood, 90 (6), pp. 2429-2436
• Ostrand-Rosenberg, S., CD4+ T lymphocytes: A critical component of antitumor immunity (2005) Cancer Investigation, 23 (5), pp. 413-419. , DOI 10.1081/CNV-67428
• Otsuki, T., Clark, H.M., Wellmann, A., Jaffe, E.S., Raffeld, M., Involvement of CDKN2 (p16INK4A/MTS1) and p15INK4B/MTS2 in human leukemias and lymphomas (1995) Cancer Res., 55, pp. 1436-1440
• Palumbo, M.L., Canzobre, M.C., Pascuan, C.G., Ríos, H., Wald, M., Genaro, A.M., Stress induced cognitive deficit is differentially modulated in BALB/c and C57Bl/6 mice: Correlation with Th1/Th2 balance after stress exposure (2010) J. Neuroimmunol., 218, pp. 12-20
• Pellegrino, T.C., Bayer, B.M., Modulation of immune cell function following fluoxetine administration in rats (1998) Pharmacol. Biochem. Behav., 59, pp. 151-157
• Pellegrino, T.C., Bayer, B.M., Specific serotonin reuptake inhibitor-induced decreases in lymphocyte activity require endogenous serotonin release (2000) NeuroImmunoModulation, 8 (4), pp. 179-187. , DOI 10.1159/000054278
• Ramos-Payán, R., Aguilar-Medina, M., Estrada-Parra, S., González-Y-Merchand, J.A., Favila-Castillo, L., Monroy-Ostria, A., Estrada-Garcia, I.C., Quantification of cytokine gene expression using an economical real-time polymerase chain reaction method based on SYBR Green I (2003) Scand. J. Immunol., 57, pp. 439-445
• Rapanelli, M., Frick, L.R., Zanutto, B.S., Learning an operant conditioning task differentially induces gliogenesis in the medial prefrontal cortex and neurogenesis in the hippocampus (2011) PLoS One, 6, pp. e14713
• Rook, A.H., Wood, G.S., Yoo, E.K., Elenitsas, R., Kao, D.M.F., Sherman, M.L., Witmer, W.K., Vonderheid, E.C., Interleukin-12 therapy of cutaneous T-cell lymphoma induces lesion regression and cytotoxic T-cell responses (1999) Blood, 94 (3), pp. 902-908
• Serafeim, A., Holder, M.J., Grafton, G., Chamba, A., Drayson, M.T., Luong, Q.T., Bunce, C.M., Gordon, J., Selective serotonin reuptake inhibitors directly signal for apoptosis in biopsy-like Burkitt lymphoma cells (2003) Blood, 101 (8), pp. 3212-3219. , DOI 10.1182/blood-2002-07-2044
• Spanova, A., Kovaru, H., Lisa, V., Lukasova, E., Rittich, B., Estimation of apoptosis in C6 glioma cells treated with antidepressants (1997) Physiol. Res., 46, pp. 161-164
• Steingart, A.B., Cotterchio, M., Do antidepressants cause, promote, or inhibit cancers? (1995) J. Clin. Epidemiol., 48, pp. 1407-1412
• Teramoto, N., Pokrovskaja, K., Szekely, L., Polack, A., Yoshino, T., Akagi, T., Klein, G., Expression of cyclin D2 and D3 in lymphoid lesions (1999) Int. J. Cancer, 81, pp. 543-850
• Xia, Z., Karlsson, H., DePierre, J.W., Nässberger, L., Tricyclic antidepressants induce apoptosis in human T lymphocytes (1997) Int. J. Immunopharmacol., 19, pp. 645-654
• Xia, Z., DePierre, J.W., Nässberger, L., Modulation of apoptosis induced by tricyclic antidepressants in human peripheral lymphocytes (1998) J. Biochem. Mol. Toxicol., 12, pp. 115-123
• Xia, Z., Bergstrand, A., DePierre, J.W., Nassberger, L., The antidepressants imipramine, clomipramine, and citalopram induce apoptosis in human acute myeloid leukemia HL-60 cells via caspase-3 activation (1999) J. Biochem. Mol. Toxicol., 13, pp. 338-347
• Xiao, L., Eneroth, P., Tricyclic antidepressants inhibit human natural killer cells (1996) Toxicol. Appl. Pharmacol., 137, pp. 157-162
• Zhang, C.-L., Kamarashev, J., Qin, J.-Z., Burg, G., Dummer, R., Dobbeling, U., Expression of apoptosis regulators in cutaneous T-cell lymphoma (CTCL) cells (2003) Journal of Pathology, 200 (2), pp. 249-254. , DOI 10.1002/path.1341

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------